Provided by Tiger Fintech (Singapore) Pte. Ltd.

Warrior Met Coal LLC

46.79
-0.2600-0.55%
Post-market: 46.790.00000.00%18:27 EDT
Volume:798.23K
Turnover:37.19M
Market Cap:2.46B
PE:23.24
High:47.15
Open:46.03
Low:45.77
Close:47.05
Loading ...

Merck Breaks Ground on New $1 Billion Biologics Center of Excellence in Wilmington, Delaware

Business Wire
·
29 Apr

KEYTRUDA® (pembrolizumab) as Perioperative Treatment With Standard of Care (SOC) Adjuvant Therapy Significantly Improved Event-Free Survival Compared to SOC Alone in Patients With Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma

Business Wire
·
28 Apr

Warrior Met Coal (NYSE:HCC) Is Due To Pay A Dividend Of $0.08

Simply Wall St.
·
27 Apr

Agenus’ BOT/BAL Data in Pretreated Liver Cancer Presented at AACR 2025

Business Wire
·
26 Apr

Jazz Pharmaceuticals Receives CHMP Positive Opinion for Zanidatamab for the Treatment of Advanced HER2-Positive Biliary Tract Cancer

PR Newswire
·
25 Apr

Earnings Preview: Peabody Energy (BTU) Q1 Earnings Expected to Decline

Zacks
·
24 Apr

Bristol Myers Squibb Reports First Quarter Financial Results for 2025

Business Wire
·
24 Apr

Warrior Met Coal Keeps Quarterly Dividend at $0.08/Share, Payable May 12 to Holders of Record May 5

MT Newswires Live
·
24 Apr

Press Release: Warrior Announces Regular Quarterly Cash Dividend

Dow Jones
·
24 Apr

Analysts Estimate Warrior Met Coal (HCC) to Report a Decline in Earnings: What to Look Out for

Zacks
·
23 Apr

Mining Shares Advance Following Trump Revamp of Approval Process

MT Newswires Live
·
21 Apr

Trump to fast-track permitting for 10 mining projects across US

Reuters
·
18 Apr

White House Says Move Will 'Create Jobs, Fuel Prosperity, and Significantly Reduce Our Reliance on Foreign Nations' for Minerals

THOMSON REUTERS
·
18 Apr

Projects From Perpetua Resources, Rio Tinto, Hecla Mining, Albemarle, Warrior Met Coal, Others to Receive Fast-Track Permitting

THOMSON REUTERS
·
18 Apr

Trump Administration Says It Will Fast-Track Permitting for 10 Mining Projects Across United States

THOMSON REUTERS
·
18 Apr

Following FDA Compassionate Use Approval for Pancreatic Carcinoma with Can-Fite’s Namodenoson, Leading U.S. Medical Centers Seek Authorization for their Patients

GlobeNewswire
·
17 Apr

Press Release: Warrior Sets Date for First Quarter 2025 Earnings Announcement and Investor Conference Call

Dow Jones
·
15 Apr

Bristol Myers says FDA approves Opdivo plus Yervoy as first-line HCC treatment

TIPRANKS
·
12 Apr

Warrior Met Coal Is Maintained at Buy by B. Riley Securities

Dow Jones
·
11 Apr

Tempest Announces Plan to Explore Strategic Alternatives to Advance Promising Pipeline of Clinical Oncology Assets and Maximize Stockholder Value

GlobeNewswire
·
10 Apr